See more : Revelstone Capital Acquisition Corp. (RCACW) Income Statement Analysis – Financial Results
Complete financial analysis of JD Health International Inc. (JDHIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of JD Health International Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Yangzhou Guangling District Taihe Rural Micro-finance Company Limited (1915.HK) Income Statement Analysis – Financial Results
- BerGenBio ASA (BRRGF) Income Statement Analysis – Financial Results
- Bomin Electronics Co., Ltd. (603936.SS) Income Statement Analysis – Financial Results
- Benchmark Holdings plc (BMK.L) Income Statement Analysis – Financial Results
- Liechtensteinische Landesbank Aktiengesellschaft (0RP8.L) Income Statement Analysis – Financial Results
JD Health International Inc. (JDHIF)
About JD Health International Inc.
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 53.53B | 46.74B | 30.68B | 19.38B | 10.84B | 8.17B | 5.55B |
| Cost of Revenue | 41.66B | 36.84B | 23.48B | 14.47B | 8.03B | 6.19B | 4.17B |
| Gross Profit | 11.87B | 9.89B | 7.20B | 4.92B | 2.81B | 1.98B | 1.38B |
| Gross Profit Ratio | 22.17% | 21.16% | 23.46% | 25.37% | 25.94% | 24.23% | 24.86% |
| Research & Development | 1.23B | 1.07B | 892.91M | 609.07M | 338.24M | 218.28M | 122.67M |
| General & Administrative | 2.00B | 2.15B | 5.54B | 2.52B | 1.25B | 1.03B | 714.85M |
| Selling & Marketing | 2.65B | 2.20B | 2.13B | 1.43B | 746.01M | 391.82M | 257.98M |
| SG&A | 10.01B | 4.35B | 7.67B | 3.96B | 1.99B | 1.42B | 972.83M |
| Other Expenses | 0.00 | 82.52M | 145.15M | -17.49B | -1.26B | 3.56M | -221.00K |
| Operating Expenses | 11.23B | 9.94B | 8.56B | 4.57B | 2.38B | 1.67B | 1.12B |
| Cost & Expenses | 52.90B | 46.78B | 32.05B | 19.03B | 10.41B | 7.86B | 5.30B |
| Interest Income | 1.95B | 864.27M | 457.57M | 149.12M | 31.78M | 84.00K | 4.00K |
| Interest Expense | 9.49M | 9.10M | 6.00M | 3.42M | 35.50M | 150.00K | 82.00K |
| Depreciation & Amortization | 227.46M | 140.68M | 63.17M | 27.22M | 7.42M | 6.27M | 3.09M |
| EBITDA | 794.92M | 943.79M | -832.32M | -17.04B | -791.78M | 317.03M | 259.16M |
| EBITDA Ratio | 1.48% | 2.02% | -2.59% | -87.92% | -7.29% | 3.88% | 4.67% |
| Operating Income | 630.85M | 803.11M | -857.14M | -17.07B | -797.34M | 310.77M | 256.07M |
| Operating Income Ratio | 1.18% | 1.72% | -2.79% | -88.06% | -7.35% | 3.80% | 4.61% |
| Total Other Income/Expenses | 2.06B | 840.93M | 502.55M | -17.07B | -37.36M | -890.00K | -89.00K |
| Income Before Tax | 2.69B | 695.81M | -901.49M | -17.07B | -834.70M | 306.23M | 255.98M |
| Income Before Tax Ratio | 5.03% | 1.49% | -2.94% | -88.08% | -7.70% | 3.75% | 4.61% |
| Income Tax Expense | 550.47M | 312.58M | 171.33M | 162.76M | 137.11M | 91.31M | 77.45M |
| Net Income | 2.14B | 380.11M | -1.07B | -17.23B | -971.81M | 214.93M | 178.53M |
| Net Income Ratio | 4.00% | 0.81% | -3.50% | -88.92% | -8.96% | 2.63% | 3.22% |
| EPS | 0.68 | 0.12 | -0.35 | -5.41 | -0.31 | 0.07 | 0.06 |
| EPS Diluted | 0.68 | 0.12 | -0.35 | -5.41 | -0.31 | 0.07 | 0.06 |
| Weighted Avg Shares Out | 3.15B | 3.11B | 3.09B | 3.18B | 3.18B | 3.13B | 3.13B |
| Weighted Avg Shares Out (Dil) | 3.16B | 3.14B | 3.09B | 3.18B | 3.18B | 3.13B | 3.13B |
Source: https://incomestatements.info
Category: Stock Reports